• Corpus ID: 119070266

Chapter 8 Lentiviral Vectors

  title={Chapter 8 Lentiviral Vectors},
  author={Marc Giry-Laterri{\`e}re and Els Verhoeyen and Patrick Salmon},
Lentiviral vectors have evolved over the last decade as powerful, reliable, and safe tools for stable gene transfer in a wide variety of mammalian cells. Contrary to other vectors derived from oncoretroviruses, they allow for stable gene delivery into most nondividing primary cells. In particular, lentivectors (LVs) derived from HIV-1 have gradually evolved to display many desirable features aimed at increasing both their safety and their versatility. This is why lentiviral vectors are becoming… 

Figures and Tables from this paper


Modifying the host range properties of retroviral vectors
This review describes the current state of the understanding of the structure and function of the retroviral envelope glycoprotein complex and discusses the results of the various strategies that have been devised to modify the host range of the retrospective glycoproteins with a view to achieving Retroviral vectors capable of delivering their genes in a highly specific manner to selected human target cells.
Strategies for targeting lentiviral vectors.
An overview of innovative approaches to upgrade lentiviral vectors for tissue or cell targeting and which have potential for in vivo gene delivery is provided.
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
An HIV vector system in which the virulence genes env, vif, vpr, vpu, and nef have been deleted is described, and this multiply attenuated vector conserved the ability to transduce growth-arrested cells and monocyte-derived macrophages in culture, and could efficiently deliver genes in vivo into adult neurons.
A Third-Generation Lentivirus Vector with a Conditional Packaging System
It is demonstrated that the requirement for the tat gene can be offset by placing constitutive promoters upstream of the vector transcript, and the improved design presented here should facilitate testing of lentivirus vectors.
Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery
The inactivation design achieved in this work improves significantly the biosafety of HIV-derived vectors, as it reduces the likelihood that replication-competent retroviruses will originate in the vector producer and target cells, and hampers recombination with wild-type HIV in an infected host.
Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences
The results indicate that nuclear translocation of the genome is a rate-limiting step in lentiviral infection of both dividing and non-dividing cells, and that it depends on protein and nucleic acid sequence determinants.
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
The ability of HIV-based viral vectors to deliver genes in vivo into nondividing cells could increase the applicability of retroviral vectors in human gene therapy.
Preferential transduction of human hepatocytes with lentiviral vectors pseudotyped by Sendai virus F protein.
  • C. Kowolik, J. Yee
  • Biology, Medicine
    Molecular therapy : the journal of the American Society of Gene Therapy
  • 2002
It is demonstrated that vectors derived from human immunodeficiency virus can be pseudotyped with Sendai virus fusion protein F and this study may facilitate HIV vector-mediated gene delivery into liver in vivo.
Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes.
The results indicate that lentivectors can be used to mediate the reversible immortalization of primary nondividing cells and should allow for the production of large supplies of a wide variety of human cells for both therapeutic and research purposes.
Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations.
This RCL assay for lentiviral vectors is based on the principles used for retroviral vectors, using a highly permissive cell line, C8166-45, for RCL amplification and an appropriate positive control virus to establish the assay sensitivity.